The following studies are in development and undergoing IRB submission and review
RIKEE1: Genotype/ phenotype correlations in KCNQ2 associated epilepsy and developmental delay
RIKEE2: Phase 1 study of ezogabine in infants and children
RIKEE 3: Phase 2/ 3 study of ezogabine in infants and children
The Molecular Neuropharmacology Lab at Baylor College of Medicine is studying the consequences of Q2 Deficiency mutations and testing therapies using in vitro and in vivo rodent models.
DO YOU REALLY WANT TO INCLUDE CURRENT RESEARCH TAB?